These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6173744)

  • 21. Endogenous opiates and schizophrenia: directions in clinical research.
    Goldbloom DS
    Can J Psychiatry; 1984 Jun; 29(4):355-60. PubMed ID: 6145518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hla, and the response to treatment with gamma-type endorphins in schizophrenia.
    de Jongh BM; Verhoeven WM; van Ree JM; de Wied D; van Rood JJ
    J Immunogenet; 1982 Dec; 9(6):381-8. PubMed ID: 6186747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opposite interactions between alpha- and beta-endorphin fragments with dopamine mediated responses on the rat rectum in vitro.
    Nijkamp FP; van Ree JM; Nijssen JG; Versluis M; de Wied D
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Dec; 321(3):213-7. PubMed ID: 6185856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short-lived effect of (Des-Tyr)-gamma-endorphin in schizophrenia.
    Volavka J; Hui KS; Anderson B; Nemes Z; O'Donnell J; Lajtha A
    Psychiatry Res; 1983 Dec; 10(4):243-52. PubMed ID: 6583715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical studies on the role of endorphins in schizophrenia.
    Berger PA; Watson SJ; Akil H; Barchas JD
    Mod Probl Pharmacopsychiatry; 1981; 17():226-35. PubMed ID: 6276727
    [No Abstract]   [Full Text] [Related]  

  • 26. Behavioral and biological effects of acute beta-endorphin injection in schizophrenic and depressed patients.
    Pickar D; Davis GC; Schulz SC; Extein I; Wagner R; Naber D; Gold PW; van Kammen DP; Goodwin FK; Wyatt RJ; Li CH; Bunney WE
    Am J Psychiatry; 1981 Feb; 138(2):160-6. PubMed ID: 6257125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Endorphins and schizophrenias. II. Trial treatment of schizophrenia with des-Tyr-gamma-endorphin (DT gamma E) (including a personal trial)].
    Bourgeois M; Laforge E; Muyard J; Blayac J; Lemoine J
    Ann Med Psychol (Paris); 1980 Nov; 138(9):1112-9. PubMed ID: 6111283
    [No Abstract]   [Full Text] [Related]  

  • 28. Criteria for evaluating improvement in schizophrenia in psychopharmacological research (with special reference to gamma endorphin fragments).
    Manchanda R; Hirsch SR; Barnes TR
    Br J Psychiatry; 1988 Sep; 153():354-8. PubMed ID: 3250672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-opiate beta-endorphin fragments and dopamine--I. The neuroleptic-like gamma-endorphin fragments interfere with the behavioural effects elicited by small doses of apomorphine.
    Van Ree JM; Innemee H; Louwerens JW; Kahn RS; De Wied D
    Neuropharmacology; 1982 Nov; 21(11):1095-101. PubMed ID: 6184639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of neuroleptic drugs on endogenous opioid peptides in the rat.
    Höllt V
    Mod Probl Pharmacopsychiatry; 1981; 17():1-18. PubMed ID: 6120450
    [No Abstract]   [Full Text] [Related]  

  • 31. Plasma levels of beta-endorphin under chronic neuroleptic treatment in schizophrenic patients: failure of naloxone to counteract curative effects of neuroleptic drugs.
    Emrich HM; Höllt V; Bergmann M; Kissling W; Schmid W; Zerssen DV; Herz A
    Adv Biochem Psychopharmacol; 1980; 22():489-502. PubMed ID: 6104902
    [No Abstract]   [Full Text] [Related]  

  • 32. Gamma-type endorphins: neurolepticum-like and antipsychotic action.
    Van Ree JM; Verhoeven WM; De Wied D
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):561-7. PubMed ID: 2418467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endorphins, dopamine, and schizophrenia.
    Volavka J; Davis LG; Ehrlich YH
    Schizophr Bull; 1979; 5(2):227-39. PubMed ID: 37595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Behavioral studies on the putative gamma-type endorphin receptor using different antibodies.
    Van Ree JM; Wolterink G; Igarashi Y; Vanderschuren L; Wiegant VM; Rust CJ; Bruning HW
    Eur J Pharmacol; 1995 Jun; 279(2-3):187-96. PubMed ID: 7556400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. beta-Endorphin and schizophrenia.
    Berger PA; Watson SJ; Akil H; Elliott GR; Rubin RT; Pfefferbaum A; Davis KL; Barchas JD; Li CH
    Arch Gen Psychiatry; 1980 Jun; 37(6):635-40. PubMed ID: 7387335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Justifying neuroleptic drug treatment.
    Overall JE; Garza-Trevino E; Rhoades HM; Volkow ND; Cecil S
    Hosp Community Psychiatry; 1989 Jul; 40(7):749-51. PubMed ID: 2570741
    [No Abstract]   [Full Text] [Related]  

  • 37. Dopamine agonist treatment of schizophrenia with N-propylnorapomorphine.
    Tamminga CA; Gotts MD; Thaker GK; Alphs LD; Foster NL
    Arch Gen Psychiatry; 1986 Apr; 43(4):398-402. PubMed ID: 2869745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A treatment trial with an analog of thyrotropin-releasing hormone (DN-1417) and des-tyrosine-gamma-endorphin in schizophrenia.
    Mizuki Y; Ushijima I; Yamada M; Tanaka M; Inanaga K
    Int Clin Psychopharmacol; 1986 Oct; 1(4):303-13. PubMed ID: 2881964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. No correlation between neuroleptic-induced increase of beta-endorphin serum level and therapeutic efficacy in schizophrenia.
    Naber D; Nedopil N; Eben E
    Br J Psychiatry; 1984 Jun; 144():651-3. PubMed ID: 6146374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. beta-Endorphin studies in psychiatric patients.
    Gorelick DA; Catlin DH; Gerner RH
    Mod Probl Pharmacopsychiatry; 1981; 17():236-45. PubMed ID: 6276728
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.